Clinical trial
Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With…
NCT00004232 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00004232 |
|---|---|
| Title | Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer |
| Official title | Augmenting Bone Marrow With CD34 Enriched Peripheral Blood Hematopoietic Stem Cells for Allogeneic Transplantation of Hematologic Malignancies |
| Lead sponsor | Northwestern University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous/Nonmalignant Condition |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, cyclosporine, methylprednisolone, prednisone, allogeneic bone marrow transplantation, peripheral blood stem cell transplantation |
| Start date | Oct 1, 1999 |
| Primary completion | Oct 1, 2002 |
| Completion | Oct 1, 2002 |
| First posted | May 9, 2003 |
| Last update posted | Jun 1, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: